tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Tiziana Life Sciences Unveils Promising Alzheimer’s Treatment Findings

Story Highlights
  • Tiziana Life Sciences announced significant findings from Alzheimer’s treatment with intranasal foralumab.
  • The study showed immune modulation and potential for clearing amyloid plaques, marking a milestone in therapy development.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Tiziana Life Sciences Unveils Promising Alzheimer’s Treatment Findings

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Tiziana Life Sciences ( (TLSA) ) has shared an update.

On July 21, 2025, Tiziana Life Sciences announced significant immunologic findings from the treatment of a moderate Alzheimer’s Disease patient using intranasal foralumab. The study revealed profound immune modulatory effects, including changes in immune cell profiles and a reduction in brain inflammation. An unexpected increase in phagocytosis markers suggests potential for clearing amyloid plaques, opening new treatment avenues for Alzheimer’s. The results, which showed no side effects, mark a milestone in Alzheimer’s therapy development and highlight Tiziana’s commitment to advancing treatments for neurodegenerative disorders.

More about Tiziana Life Sciences

Tiziana Life Sciences is a clinical-stage biopharmaceutical company focused on developing breakthrough therapies using innovative drug delivery technologies. The company’s lead candidate, intranasal foralumab, is a fully human anti-CD3 monoclonal antibody currently in clinical development, with potential applications in treating neuroinflammatory and neurodegenerative diseases.

Average Trading Volume: 317,855

Technical Sentiment Signal: Buy

Current Market Cap: $172.8M

For an in-depth examination of TLSA stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1